• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Property for Industry Limited - Product Image

Property for Industry Limited

  • ID: 641970
  • February 2015
  • 53 Pages
  • Wright Investors Service

A textual analysis of the financial results for Property for Industry Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description of the company, including contact information, senior officers and Wright Quality Rating analyses is also provided.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Property for Industry Limited. There is a textual review of the financial results of Property for Industry Limited versus DNZ Property Fund Limited, J. Smart & Co. (Contractors) PLC and Gromutual Berhad. The comparative analysis of these companies READ MORE >

Note: Product cover images may vary from those shown

Company Fundamentals
- Company Profile
- Comparative Business Analysis
- Summary Analysis per Share
- Sales Analysis
- Price Analysis
- Earnings and Dividends Analysis

Financial Statement Analyses
- Balance Sheet - Common Size
- Balance Sheet - Year-Year Percent Change
- Balance Sheet - Five-Year Averages
- Income Statement - Common Size
- Income Statement - Year-Year Percent Change
- Income Statement - Five-Year Averages
- Sources of Capital

Financial Ratio Analyses
- Accounting Ratios
- Asset Utilization
- Employee Efficiency
- Fixed Charges Coverage
- Leverage Analysis
- Liquidity Analysis
- Per-Share Data
- Profitability Analysis

Wright Quality Rating Analyses
- Investment Acceptance
- Financial Strength
- Profitability and Stability
- Corporate Growth

Note: Product cover images may vary from those shown

New Zealand

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

  • Simon Property Group, Inc. - Product Thumbnail Image

    Simon Property Group, Inc.

    • Language: English
    • 39 Pages
    • Published: February 2015
    FROM
  • Dear Life Co Ltd - Product Thumbnail Image

    Dear Life Co Ltd

    • Language: English
    • 55 Pages
    • Published: February 2015
    FROM
  • DNZ Property Fund Limited - Product Thumbnail Image

    DNZ Property Fund Limited

    • Language: English
    • 50 Pages
    • Published: February 2015
    FROM
  • SBC Corporation Berhad - Product Thumbnail Image

    SBC Corporation Berhad

    • Language: English
    • 53 Pages
    • Published: March 2015
    FROM
  • Singapore Airlines Limited - Product Thumbnail Image

    Singapore Airlines Limited

    • Language: English
    • 54 Pages
    • Published: March 2015
    • Region: Singapore
    FROM
  • Brem Holdings Berhad - Product Thumbnail Image

    Brem Holdings Berhad

    • Language: English
    • 54 Pages
    • Published: March 2015
    FROM
  • Gromutual Berhad - Product Thumbnail Image

    Gromutual Berhad

    • Language: English
    • 53 Pages
    • Published: March 2015
    FROM
  • Select Group Limited - Product Thumbnail Image

    Select Group Limited

    • Language: English
    • 55 Pages
    • Published: March 2015
    FROM
  • Godrej Industries Limited - Product Thumbnail Image

    Godrej Industries Limited

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM
  • Y&G Corporation Bhd - Product Thumbnail Image

    Y&G Corporation Bhd

    • Language: English
    • 55 Pages
    • Published: April 2015
    FROM

Our Clients

Fluidigm Corporation Apple, Inc. CEVA Santé Animale Abbott Laboratories Ltd. Merck Group Allergan Inc. Pfizer, Inc.